NASDAQ : ZVRA
Zevra Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.36 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 615.22M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Zevra Therapeutics, Inc. (ZVRA) reported revenue of 136.07M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 136.07M | 106.47M | 23.61M | 27.46M | 10.16M | 28.65M |
| Cost of Revenue | 6.18M | 16.48M | 7.42M | 2.17M | 222.00K | 2.06M |
| Gross Profit | 129.89M | 89.99M | 16.20M | 25.29M | 9.94M | 26.59M |
| Selling, General & Admin | 74.73M | 77.71M | 54.92M | 35.09M | 15.61M | 9.23M |
| Research & Development | 14.83M | 12.65M | 42.04M | 39.03M | 19.23M | 9.64M |
| Amortization of Goodwill & Intangibles | 1.26M | 3.86M | 6.24M | 772.00K | ||
| Operating Expenses | 90.82M | 94.22M | 103.20M | 74.89M | 34.84M | 18.86M |
| Operating Income | 39.07M | -4.23M | -87.00M | -49.60M | -24.90M | 7.73M |
| Interest Expense | -5.71M | -7.98M | -7.35M | -1.50M | -335.00K | -376.00K |
| Interest & Investment Income | 10.18M | 6.95M | 2.17M | 4.54M | 1.51M | 261.00K |
| Other Non Operating Income (Expenses) | -7.39M | 2.18M | 2.06M | -98.00K | 15.16M | -26.00K |
| EBT Excluding Unusual Items | 36.15M | -3.09M | -90.12M | -46.66M | -8.56M | 7.59M |
| Gain (Loss) on Sale of Investments | -202.00K | 149.00K | -18.00K | 613.00K | -577.00K | -13.00K |
| Gain (Loss) on Sale of Assets | 43.31M | 148.32M | ||||
| Asset Writedown | -58.71M | |||||
| Other Unusual Items | -9.97M | -16.10M | ||||
| Pretax Income | 69.29M | 86.68M | -90.14M | -46.05M | -26.80M | -8.52M |
| Income Tax Expense | 11.03M | 3.45M | 15.37M | -33.00K | 34.00K | |
| Net Income | 58.26M | 83.23M | -105.51M | -46.05M | -26.77M | -8.55M |
| Preferred Dividends & Other Adjustments | 1.02M | 5.64M | 54.34M | |||
| Net Income to Common | 57.25M | 77.58M | -105.51M | -46.05M | -26.77M | -62.90M |
| Shares Outstanding (Basic) | 57.48M | 55.31M | 46.25M | 35.45M | 34.49M | 29.77M |
| Shares Outstanding (Diluted) | 59.62M | 57.26M | 46.25M | 35.45M | 34.49M | 29.77M |
| EPS (Basic) | 1.00 | 1.40 | -2.28 | -1.30 | -0.78 | -2.11 |
| EPS (Diluted) | 0.96 | 1.35 | -2.28 | -1.30 | -0.78 | -2.11 |
| Free Cash Flow | 32.62M | -2.43M | -69.67M | -33.83M | -18.81M | 10.34M |
| Free Cash Flow Per Share | 0.55 | -0.04 | -1.51 | -0.95 | -0.55 | 0.35 |
| Gross Margin | 95.46% | 84.52% | 68.59% | 92.09% | 97.81% | 92.81% |
| Operating Margin | 28.71% | -3.98% | -368.47% | -180.63% | -245.07% | 26.98% |
| Profit Margin | 42.07% | 72.87% | -446.85% | -167.69% | -263.48% | -219.54% |
| Free Cash Flow Margin | 23.98% | -2.28% | -295.04% | -123.20% | -185.12% | 36.08% |
| EBITDA | 40.55M | -179.00K | -80.61M | -48.60M | -23.96M | 7.99M |
| EBITDA Margin | 29.80% | -0.17% | -176.97% | -235.78% | 27.87% | |
| D&A For EBITDA | 1.49M | 4.05M | 6.39M | 1.01M | 944.00K | 257.00K |
| EBIT | 39.07M | -4.23M | -87.00M | -49.60M | -24.90M | 7.73M |
| EBIT Margin | 28.71% | -3.98% | -180.63% | -245.07% | 26.98% | |
| Effective Tax Rate | 15.91% | 3.98% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 145.32M | 62.41M | 33.78M | 43.05M | 65.47M | 112.35M |
| Short-Term Investments | 76.25M | 128.60M | 35.71M | 24.69M | 17.38M | |
| Cash & Short-Term Investments | 221.57M | 191.01M | 69.50M | 67.74M | 82.85M | 112.35M |
| Accounts Receivable | 10.33M | 11.66M | 4.80M | 16.12M | 7.18M | 1.42M |
| Other Receivables | 12.16M | 11.60M | 5.71M | 1.26M | 1.11M | 107.00K |
| Receivables | 22.49M | 23.26M | 10.51M | 17.38M | 8.30M | 1.53M |
| Inventory | 2.45M | 1.74M | 1.97M | |||
| Prepaid Expenses | 4.79M | 7.00M | 4.05M | 1.82M | 1.69M | 889.00K |
| Other Current Assets | 293.00K | |||||
| Total Current Assets | 251.30M | 223.01M | 86.03M | 86.94M | 92.83M | 115.06M |
| Property, Plant & Equipment | 2.31M | 1.70M | 1.01M | 1.53M | 1.78M | 2.02M |
| Long-Term Investments | 38.61M | 47.88M | 6.01M | 20.00M | 15.42M | |
| Goodwill | 4.70M | 4.70M | 4.70M | 4.70M | ||
| Other Intangible Assets | 5.79M | 6.42M | 68.99M | 69.23M | ||
| Other Long-Term Assets | 3.00K | 1.02M | 11.38M | 9.94M | 724.00K | 438.00K |
| Total Assets | 302.71M | 284.73M | 178.13M | 172.33M | 115.34M | 132.94M |
| Accounts Payable | 13.96M | 2.48M | 13.07M | 13.99M | 3.61M | 516.00K |
| Accrued Expenses | 11.78M | 21.31M | 18.31M | 18.97M | 7.21M | 2.52M |
| Short-Term Debt | 37.70M | |||||
| Current Portion of Leases | 626.00K | 419.00K | 420.00K | 543.00K | 486.00K | 371.00K |
| Current Income Taxes Payable | 20.84M | 13.71M | ||||
| Other Current Liabilities | 1.42M | 1.36M | 2.26M | 2.52M | 713.00K | 821.00K |
| Total Current Liabilities | 48.63M | 39.28M | 34.06M | 73.72M | 12.02M | 4.23M |
| Long-Term Debt | 61.93M | 59.50M | 5.07M | 12.80M | ||
| Long-Term Leases | 870.00K | 859.00K | 372.00K | 456.00K | 843.00K | 1.24M |
| Other Long-Term Liabilities | 35.56M | 28.01M | 44.52M | 31.22M | 14.55M | 355.00K |
| Total Liabilities | 85.06M | 130.07M | 138.46M | 110.46M | 40.22M | 5.82M |
| Common Stock | 6.00K | 6.00K | 5.00K | 4.00K | 3.00K | 4.00K |
| Additional Paid-In Capital | 606.26M | 588.46M | 555.30M | 472.66M | 436.27M | 396.96M |
| Retained Earnings | -375.42M | -422.06M | -505.29M | -399.78M | -353.73M | -267.03M |
| Treasury Stock | -10.98M | -10.98M | -10.98M | -10.98M | -7.54M | -2.81M |
| Comprehensive Income & Other | -2.22M | -764.00K | 631.00K | -43.00K | 113.00K | |
| Shareholders' Equity | 217.65M | 154.66M | 39.67M | 61.86M | 75.12M | 127.12M |
| Total Liabilities & Equity | 302.71M | 284.73M | 178.13M | 172.33M | 115.34M | 132.94M |
| Total Debt | 1.50M | 63.21M | 60.30M | 43.77M | 14.13M | 1.61M |
| Net Cash (Debt) | 220.07M | 127.81M | 9.20M | 23.97M | 68.72M | 110.74M |
| Net Cash Per Share | 3.69 | 2.23 | 0.20 | 0.68 | 1.99 | 3.72 |
| Filing Date Shares Outstanding | 59.38M | 58.71M | 54.12M | 41.85M | 34.54M | 34.42M |
| Total Common Shares Outstanding | 59.34M | 56.85M | 53.67M | 41.53M | 34.54M | 35.01M |
| Working Capital | 202.67M | 183.73M | 51.96M | 13.22M | 80.81M | 110.83M |
| Book Value Per Share | 3.67 | 2.72 | 0.74 | 1.49 | 2.17 | 3.63 |
| Tangible Book Value | 207.16M | 143.53M | -34.03M | -12.06M | 75.12M | 127.12M |
| Tangible Book Value Per Share | 3.49 | 2.52 | -0.63 | -0.29 | 2.17 | 3.63 |
| Machinery | 661.00K | 1.36M | 1.51M | 1.28M | 1.05M | |
| Leasehold Improvements | 139.00K | 710.00K | 710.00K | 710.00K | 724.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 58.26M | 83.23M | -105.51M | -46.05M | -26.77M | -8.55M |
| Depreciation & Amortization | 1.49M | 4.05M | 6.39M | 1.01M | 944.00K | 257.00K |
| Other Amortization | 150.00K | |||||
| Loss (Gain) From Sale of Assets | -43.25M | -148.26M | 218.00K | 157.00K | 9.00K | 76.00K |
| Asset Writedown & Restructuring Costs | 58.71M | 17.66M | ||||
| Loss (Gain) From Sale of Investments | -3.08M | -3.28M | -872.00K | -613.00K | 577.00K | |
| Stock-Based Compensation | 13.13M | 12.71M | 15.38M | 6.18M | 4.52M | 2.74M |
| Other Operating Activities | 10.58M | 17.75M | 21.92M | -100.00K | -15.25M | 16.13M |
| Change in Accounts Receivable | -3.86M | -11.98M | 6.87M | -9.08M | -6.77M | 1.05M |
| Change in Inventory | -1.04M | -1.30M | -8.87M | 206.00K | 147.00K | |
| Change in Accounts Payable | -2.53M | -15.59M | -3.60M | 11.13M | 3.13M | -1.11M |
| Change in Other Net Operating Assets | 3.71M | 2.36M | -1.59M | 3.62M | 3.09M | -295.00K |
| Operating Cash Flow | 33.40M | -1.60M | -69.67M | -33.53M | -18.72M | 10.44M |
| Capital Expenditures | -775.00K | -835.00K | -296.00K | -93.00K | -102.00K | |
| Sale of Property, Plant & Equipment | 49.38M | 448.00K | ||||
| Cash Acquisitions | -30.40M | -14.09M | ||||
| Investment in Securities | 58.11M | -131.49M | -16.16M | 13.31M | -22.54M | -15.42M |
| Other Investing Activities | 150.00M | -6.00M | ||||
| Investing Cash Flow | 106.72M | 18.13M | -22.16M | -17.39M | -36.72M | -15.52M |
| Long-Term Debt Issued | 60.07M | 43.69M | 14.07M | |||
| Long-Term Debt Repaid | -372.00K | -43.13M | -18.10M | -1.32M | -38.10M | |
| Net Debt Issued (Repaid) | -60.09M | -372.00K | 16.94M | 25.59M | 12.75M | -38.10M |
| Issuance of Common Stock | 19.43M | 12.44M | 67.26M | 6.32M | 324.00K | 158.24M |
| Repurchase of Common Stock | -1.49M | -3.45M | -4.72M | -2.81M | ||
| Other Financing Activities | -2.09M | -4.22M | ||||
| Financing Cash Flow | -42.14M | 12.06M | 82.11M | 28.46M | 8.35M | 113.11M |
| Foreign Exchange Rate Adjustments | -367.00K | 28.00K | 454.00K | 44.00K | 204.00K | |
| Net Cash Flow | 97.61M | 28.62M | -9.26M | -22.42M | -46.88M | 108.02M |
| Free Cash Flow | 32.62M | -2.43M | -69.67M | -33.83M | -18.81M | 10.34M |
| Free Cash Flow Margin | 23.98% | -2.28% | -295.04% | -123.20% | -185.12% | 36.08% |
| Free Cash Flow Per Share | 0.55 | -0.04 | -1.51 | -0.95 | -0.55 | 0.35 |
| Levered Free Cash Flow | 48.38M | -1.96M | -36.36M | -10.32M | -10.00M | 6.31M |
| Unlevered Free Cash Flow | 51.95M | 3.03M | -31.77M | -9.39M | -9.79M | 6.39M |
| Cash Interest Paid | 4.07M | 5.33M | 5.26M | 456.00K | 321.00K | 218.00K |
| Change in Working Capital | -3.72M | -26.51M | -7.19M | 5.88M | -406.00K | -357.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 610.47M | 504.43M | 445.16M | 271.73M | 158.38M | 307.63M |
| Enterprise Value | 390.39M | 367.63M | 415.71M | 233.13M | 96.72M | 177.84M |
| Last Close Price | 10.28 | 8.96 | 8.34 | 6.55 | 4.59 | 8.71 |
| PE Ratio | 10.71 | 6.50 | ||||
| Forward PE | 12.05 | 19.14 | 102.50 | 102.50 | 102.50 | 24.17 |
| PS Ratio | 4.49 | 4.74 | 18.85 | 9.89 | 15.59 | 10.74 |
| PB Ratio | 2.80 | 3.26 | 11.22 | 4.39 | 2.11 | 2.42 |
| P/TBV Ratio | 2.95 | 3.51 | 2.11 | 2.42 | ||
| P/FCF Ratio | 18.71 | 29.76 | ||||
| P/OCF Ratio | 18.28 | 29.47 | ||||
| EV/Sales Ratio | 2.87 | 3.45 | 17.61 | 8.49 | 9.52 | 6.21 |
| EV/EBITDA Ratio | 9.63 | 22.27 | ||||
| EV/EBIT Ratio | 9.99 | 23.01 | ||||
| EV/FCF Ratio | 11.97 | 17.20 | ||||
| Debt / Equity Ratio | 0.01 | 0.41 | 1.52 | 0.71 | 0.19 | 0.01 |
| Debt / EBITDA Ratio | 0.04 | 92.54 | 0.18 | |||
| Debt / FCF Ratio | 0.05 | 0.16 | ||||
| Net Debt / Equity Ratio | -1.01 | -0.83 | -0.23 | -0.39 | -0.92 | -0.87 |
| Net Debt / EBITDA Ratio | -5.43 | 713.99 | 0.11 | 0.49 | 2.87 | -13.87 |
| Net Debt / FCF Ratio | -6.75 | 52.53 | 0.13 | 0.71 | 3.65 | -10.71 |
| Asset Turnover | 0.49 | 0.46 | 0.14 | 0.19 | 0.08 | 0.40 |
| Inventory Turnover | 3.48 | 8.88 | ||||
| Quick Ratio | 5.02 | 5.46 | 2.35 | 1.16 | 7.58 | 26.92 |
| Current Ratio | 5.17 | 5.68 | 2.52 | 1.18 | 7.72 | 27.20 |
| Return on Equity (ROE) | 34.80% | 85.66% | -207.84% | -67.23% | -26.48% | -28.18% |
| Return on Assets (ROA) | 8.74% | -1.14% | -31.03% | -21.55% | -12.54% | 6.70% |
| Return on Invested Capital (ROIC) | -14.18% | -254.55% | -223.98% | -218.60% | 77.08% | |
| Return on Capital Employed (ROCE) | 15.40% | -1.70% | -60.40% | -50.30% | -24.10% | 6.00% |
| Earnings Yield | 9.34% | 16.50% | -23.70% | -16.95% | -16.90% | -2.78% |
| FCF Yield | 5.34% | -0.48% | -15.65% | -12.45% | -11.88% | 3.36% |
| Buyback Yield / Dilution | -13.46% | -23.81% | -30.46% | -2.79% | -15.87% | -647.72% |